Anabel Costa-Ferreira
Editorial Intern
Anabel is an Editorial and Data Journalism Intern, working primarily within the In Vivo team.
Before joining Norstella, she recently completed a BA English degree at the University of Exeter. Anabel has also spent the past year as Editor-in-Chief of her university’s student paper Exeposé, managing an editorial team to produce a 32-page paper on a fortnightly basis.
During her internship, she is eager to expand her journalistic knowledge, write articles and work on data projects – all as she looks forward to entering the world of biopharma.
-
Writes for In Vivo
Latest From Anabel Costa-Ferreira
Ashibio Takes Shelved Gilead Drug In New Direction
-
Interviews
On the back of a “truly one in a million” case, Ashibio has revived research into Gilead's discontinued asset andecaliximab after it showed promise in the ultra-rare musculoskeletal condition FOP.
Email Author
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.